208 related articles for article (PubMed ID: 38618716)
1. Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I/R Injury.
Mendoza A; Patel P; Robichaux D; Ramirez D; Karch J
Circ Res; 2024 May; 134(10):1292-1305. PubMed ID: 38618716
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury.
Panel M; Ruiz I; Brillet R; Lafdil F; Teixeira-Clerc F; Nguyen CT; Calderaro J; Gelin M; Allemand F; Guichou JF; Ghaleh B; Ahmed-Belkacem A; Morin D; Pawlotsky JM
Gastroenterology; 2019 Nov; 157(5):1368-1382. PubMed ID: 31336123
[TBL] [Abstract][Full Text] [Related]
3. Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes.
Abdallah Y; Kasseckert SA; Iraqi W; Said M; Shahzad T; Erdogan A; Neuhof C; Gündüz D; Schlüter KD; Tillmanns H; Piper HM; Reusch HP; Ladilov Y
J Cell Mol Med; 2011 Nov; 15(11):2478-85. PubMed ID: 21199327
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.
Ananthakrishnan R; Kaneko M; Hwang YC; Quadri N; Gomez T; Li Q; Caspersen C; Ramasamy R
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H333-41. PubMed ID: 19060123
[TBL] [Abstract][Full Text] [Related]
5. A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.
Panel M; Ahmed-Belkacem A; Ruiz I; Guichou JF; Pawlotsky JM; Ghaleh B; Morin D
J Pharmacol Exp Ther; 2021 Mar; 376(3):348-357. PubMed ID: 33303698
[TBL] [Abstract][Full Text] [Related]
6. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
[TBL] [Abstract][Full Text] [Related]
7. Distinct mPTP activation mechanisms in ischaemia-reperfusion: contributions of Ca2+, ROS, pH, and inorganic polyphosphate.
Seidlmayer LK; Juettner VV; Kettlewell S; Pavlov EV; Blatter LA; Dedkova EN
Cardiovasc Res; 2015 May; 106(2):237-48. PubMed ID: 25742913
[TBL] [Abstract][Full Text] [Related]
8. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion.
Schriewer JM; Peek CB; Bass J; Schumacker PT
J Am Heart Assoc; 2013 Apr; 2(2):e000159. PubMed ID: 23598272
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial permeability transition pore-dependent necrosis.
Robichaux DJ; Harata M; Murphy E; Karch J
J Mol Cell Cardiol; 2023 Jan; 174():47-55. PubMed ID: 36410526
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
Hausenloy DJ; Lim SY; Ong SG; Davidson SM; Yellon DM
Cardiovasc Res; 2010 Oct; 88(1):67-74. PubMed ID: 20400621
[TBL] [Abstract][Full Text] [Related]
11. The Ca²⁺-calmodulin-Ca²⁺/calmodulin-dependent protein kinase II signaling pathway is involved in oxidative stress-induced mitochondrial permeability transition and apoptosis in isolated rat hepatocytes.
Toledo FD; Pérez LM; Basiglio CL; Ochoa JE; Sanchez Pozzi EJ; Roma MG
Arch Toxicol; 2014 Sep; 88(9):1695-709. PubMed ID: 24614978
[TBL] [Abstract][Full Text] [Related]
12. Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress.
Townsend PA; Davidson SM; Clarke SJ; Khaliulin I; Carroll CJ; Scarabelli TM; Knight RA; Stephanou A; Latchman DS; Halestrap AP
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H928-38. PubMed ID: 17483234
[TBL] [Abstract][Full Text] [Related]
13. Opening of mitochondrial permeability transition pore in cardiomyocytes: Is ferutinin a suitable tool for its assessment?
Bréhat J; Panel M; Ghaleh B; Morin D
Fundam Clin Pharmacol; 2023 Aug; 37(4):739-752. PubMed ID: 36797226
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of cyclophilin D at serine 191 regulates mitochondrial permeability transition pore opening and cell death after ischemia-reperfusion.
Hurst S; Gonnot F; Dia M; Crola Da Silva C; Gomez L; Sheu SS
Cell Death Dis; 2020 Aug; 11(8):661. PubMed ID: 32814770
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.
Chen Q; Xu H; Xu A; Ross T; Bowler E; Hu Y; Lesnefsky EJ
PLoS One; 2015; 10(3):e0118834. PubMed ID: 25756500
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion.
Boengler K; Hilfiker-Kleiner D; Heusch G; Schulz R
Basic Res Cardiol; 2010 Nov; 105(6):771-85. PubMed ID: 20960209
[TBL] [Abstract][Full Text] [Related]
18. The role of mitochondria in protection of the heart by preconditioning.
Halestrap AP; Clarke SJ; Khaliulin I
Biochim Biophys Acta; 2007 Aug; 1767(8):1007-31. PubMed ID: 17631856
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection.
Bell RM; Kunuthur SP; Hendry C; Bruce-Hickman D; Davidson S; Yellon DM
Basic Res Cardiol; 2013 Mar; 108(2):331. PubMed ID: 23361433
[TBL] [Abstract][Full Text] [Related]
20. Preconditioning or Postconditioning with 8-Br-cAMP-AM Protects the Heart against Regional Ischemia and Reperfusion: A Role for Mitochondrial Permeability Transition.
Khaliulin I; Ascione R; Maslov LN; Amal H; Suleiman MS
Cells; 2021 May; 10(5):. PubMed ID: 34067674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
